Human movement company Scientific Analytics Inc reported on Wednesday the receipt of the US FDA's 510K medical device designation for its computer-vision-powered motion health analysis technology, DARI Health.
According to the company, its markerless DARI Motion computer vision and biomechanical analysis technology has been refined by more than 425bn data points of human motion gathered across applications in wellness, military, elite athletics and healthcare. It helps people and organisations to improve performance, avoid injury and reduce unnecessary costs.
Scientific Analytics has also formed a strategic collaboration with Hospital for Special Surgery (HSS), the world's largest academic musculoskeletal health company.
The newly formed partnership will integrate leading knowledge and technology with the aim of setting new standards for full-body, dynamic motion analysis at population scale. It will provide the first medical device that will arm clinicians with an FDA-cleared, accurate and reliable solution that easily and seamlessly captures clinically-relevant human movement data at the point of care.
Through the partnership, the companies aim to create a new standard in data-driven, value-based musculoskeletal health while objectively documenting outcomes and delivering an engaging patient experience.
OSR Holdings to acquire Korean non-invasive glucose monitor developer Woori IO
Autonomix Medical secures new US patent to expand precision nerve-targeted therapies
MedHub-AI's AutocathFFR receives national reimbursement approval in Japan
Microbot Medical secures first Japanese patent for Liberty robotic system following FDA clearance
Polarean Imaging signs new supply agreementwith UVA Health for clinical Xenon MRI
Femasys partners with Kebomed to expand FemBloc permanent birth control in France and Benelux
Implantica receives positive FDA feedback on final RefluxStop PMA submission
Tempus secures FDA clearance for RNA-based xR IVD diagnostic device
Shoulder Innovations expands I-Series portfolio with launch of InSet 70 Humeral Stem
GSK commits USD30bn to US R&D and manufacturing expansion
ArtPlayer Promotes Elderly Wellbeing with Digital Signage and Streaming Art in Finnish Care Homes
Implantica produces 10,000 RefluxStop units ahead of planned US launch
Elute partners Spartan Medical
Saol Therapeutics receives US FDA Complete Response Letter for SL1009 (DCA) in PDCD